See What HealthDay Can Do For You
Contact Us

HeartWare Device Approved for Heart Transplant Hopefuls

HeartWare Ventricular Assist System approved for end-stage heart failure patients awaiting transplant

TUESDAY, Nov. 20 (HealthDay News) -- The HeartWare Ventricular Assist System, a left ventricular assist device to help people with end-stage heart failure who are awaiting a transplant, has been approved by the U.S. Food and Drug Administration.

Unlike similar devices that require components to be implanted in the abdomen, the HeartWare device is small enough to be implanted as a single unit near the heart. Approval was granted based on a clinical study of 137 advanced heart failure patients, the FDA said.

The possibility of serious adverse reactions, including stroke and infection, must be weighed against the need for the device, the agency advised.

The device is produced by HeartWare Inc., of Framingham, Mass.

More Information

Physician's Briefing

HealthDay

HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.